Medicine & Life Sciences

1. Primary Myelofibrosis 100%
2. Polycythemia Vera 54%
3. Essential Thrombocythemia 54%
4. Mutation 30%
5. Myelodysplastic Syndromes 23%
6. Survival 22%
7. Systemic Mastocytosis 19%
8. Myeloproliferative Disorders 19%
9. Bone Marrow 16%
10. Cytogenetics 15%
11. Leukemia, Myelomonocytic, Chronic 15%
12. Neoplasms 13%
13. Thrombocytosis 13%
14. Therapeutics 12%
15. Acute Myeloid Leukemia 11%
16. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11%
17. Karyotype 11%
18. Thrombosis 9%
19. Anemia 9%
20. Imatinib Mesylate 9%
21. Leukemia, Neutrophilic, Chronic 8%
22. Leukemia 8%
23. Splenomegaly 8%
24. Risk Management 8%
25. Eosinophilia 8%
26. Janus Kinase Inhibitors 7%
27. Chromosome Aberrations 7%
28. Hydroxyurea 7%
29. B-Cell Chronic Lymphocytic Leukemia 7%
30. Platelet Count 6%
31. Splenectomy 6%
32. Polycythemia 6%
33. Cladribine 6%
34. Leukocytosis 6%
35. Janus Kinase 2 6%
36. Hemoglobins 5%
37. Megakaryocytes 5%
38. INCB018424 5%
39. Allogeneic Cells 5%
40. Transplants 5%
41. anagrelide 5%
42. Stem Cell Transplantation 5%
43. Stem Cells 5%
44. Extramedullary Hematopoiesis 5%
45. Mastocytosis 5%
46. Hypereosinophilic Syndrome 5%
47. Blast Crisis 5%